Cargando…
Case Report: COVID-19-associated Rhinosinusitis Mucormycosis Caused by Rhizopus arrhizus: A Rare but Potentially Fatal Infection Occurring After Treatment with Corticosteroids
COVID-19 first emerged in Wuhan, China, in December 2019. Since that time, the frequency of bacterial and fungal coinfections has been continuously increasing. Although invasive pulmonary aspergillosis is being increasingly recognized in association with COVID-19, there is limited information regard...
Autores principales: | Tabarsi, Payam, Khalili, Neda, Pourabdollah, Mihan, Sharifynia, Somayeh, Safavi Naeini, Ali, Ghorbani, Jahangir, Mohamadnia, Abdolreza, Abtahian, Zahra, Askari, Elham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437195/ https://www.ncbi.nlm.nih.gov/pubmed/34237015 http://dx.doi.org/10.4269/ajtmh.21-0359 |
Ejemplares similares
-
Mixed etiology COVID-19 associated acute rhinosinusitis caused by two Aspergillus species
por: Tabarsi, Payam, et al.
Publicado: (2022) -
Coinfection by Aspergillus and Mucoraceae Species in Two Cases of Acute Rhinosinusitis as a Complication of COVID-19
por: Tabarsi, Payam, et al.
Publicado: (2022) -
Successful Treatment of Mucormycosis Caused by Rhizopus arrhizus With Amphotericin B and Itraconazole
por: Cham, Chen Yi, et al.
Publicado: (2023) -
Ventriculitis due to infection with Rhizopus arrhizus
por: Hagel, Stefan, et al.
Publicado: (2015) -
Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus
por: Gebremariam, Teclegiorgis, et al.
Publicado: (2020)